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Summary 
Chondrocyte-laden collagen scaffolds were evaluated in extensive cartilage defects in an equine model. Arthroscopic 
techniques were used to implant a chondrocyte-collagen culture product in 15-mm defects in the lateral trochlear ridge 
of the femoropatellar joint of 12 horses. Ungrafted control defects were formed in the opposite joint. Groups of six 
horses were terminated at 4 and 8 months after implantation and the repair sites, adjacent cartilage, and remote 
cartilage within each femoropatellar joint examined biochemically. Eight months following surgery the relative 
proportions of type II collagen in grafted and ungrafted efects, determined using the ratio f cyanogen bromide 
cleavage products ~I(II)CB10/~2(I)CB3,5, were not significantly different (31.57 + 2.76% and 26.88 _+ 2.76%, respect- 
ively). Aggrecan content was significantly improved in grafted efects (85.61 + 6.51 and 74.91 + 10.31 pg/mg dry weight). 
Cartilage surrounding rafted defects also showed improved maintenance of cartilage glycosaminoglycan content. 
Thus, chondrocyte grafting in collagen scaffold vehicles improved the aggrecan content in extensive cartilage defects 
and surrounding normal cartilage. However, given the continued isparity between repair tissue and normal cartilage 
aggrecan content, and the low proportion of type II collagen in grafted defects, the utility of collagen scaffolds for 
chondrocyte grafting of large cartilage defects eems limited. 
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Introduction 
THE major goal of art icular resurfacing is to pro- 
duce a surface that mimics hyaline carti lage in 
funct ion and durability. The function of art icular 
cartilage is determined by its molecular organiz- 
ation, structural composition, and physicochemi- 
cal structural characteristics [1, 2]. Biochemical 
analysis determines its compositional similarity to 
hyaline cartilage, an important prerequisite to 
carti lage durability. The classic markers for artic- 
ular carti lage are type II collagen, which com- 
prises 90-95% of the collagen in hyaline carti lage 
[2-5], and the aggregating proteoglycans, contain- 
ing the glycosaminoglycans (GAGs) chondroitin 
sulfate (CS) and keratan sulfate (KS) [6, 7]. Con- 
versely, fibrous tissue has primarily type I collagen 
and contains less glycosaminoglycan, which s 
predominantly dermatan sulfate [8-10]. Therefore, 
the greater the proportion of type II collagen and 
concentration of KS and CS in repair tissue, the 
closer it resembles hyaline cartilage in compo- 
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sition, and if structural ly organized, the more 
likely it is to function mechanical ly like hyal ine 
cartilage. 
Degenerative joint disease secondary to focal 
loss of art icular carti lage results in substantial 
morbidity. Isolated defects in mature carti lage 
have virtually no intrinsic repair capacity unti l  
the tide mark (calcification front) is broached or 
the underlying subchondral bone exposed [11-14]. 
Even so, the fibrous repair tissue that forms has 
only variable metaplastic capability to form fibro- 
cartilage [15], and the ability of this repair tissue 
to function as normal carti lage for an extended 
period of time has been questioned [16]. 
Because of the failure of art icular carti lage 
to hea-l~'satisfactorily, many investigations have 
pursued methods of transplantat ion resurfacing 
[17-23]. These techniques, which include peri- 
osteal, perichondrial, osteochondral and sternal 
cartilage grafting, have been reviewed [24]. None 
have been sufficiently successful to allow wide- 
spread clinical use in man or animals. Isolated 
equine chondroc:~tes have been investigated in 
various vehicles for grafting large cartilage defects 
[25, 26]. Fibrin has been used as a vehicle for 
equine chondrocytes, and at 8 months the repair 
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tissue contained 62~/o type II collagen [26]. The 
grafted defects also had significantly higher levels 
of total GAG and KS. Fibrin was successful as a 
3-dimensional culture framework; however, it 
was difficult to anchor permanently in the defect. 
Chondrocytes embedded in collagen scaffolds have 
been press-fit into defects for grafting in laboratory 
animal species and resulted in a hyaline cartilage 
repair [20, 27-29]. In vitro studies using equine 
chondrocytes howed collagen scaffolds (Colla 
Tec Inc., Plainsboro, NJ) to be acceptable culture 
vehicles [30]. The objectives of this study were to 
biochemically evaluate the matrix composition of 
the repair tissue, the surrounding cartilage, 
and cartilage remote to the implant sites, follow- 
ing implantation of chondrocyte-laden collagen 
scaffolds into articular defects in a large animal 
model of extensive cartilage loss. 
Mater ia l s  and  methods  
SURGICAL IMPLANTATION AND TISSUE HARVESTING 
The preparation of the allograft and the surgical 
technique for implantation have been described 
previously [24]. In summary, porous, modified 
bovine type 1 collagen scaffolds containing 8 x 106 
allograft-chondrocytes and coated with polymer- 
ized collagen (Vitrogen, Collagen Corporation, 
Palo Alto, CA) were arthroscopically implanted 
into 16-mm full thickness defects in the central 
aspect of the lateral trochlea of the femur of 12 
normal horses aged 2-8 years. The disc-shaped 
collagen-chondrocyte composites were anchored 
in the defect using two polylactic acid tacks (Biofix 
Minitack, B iocon  Ltd, Tampere, Finland). The 
contralateral limbs served as sham operated con- 
trol joints where a full thickness defect was 
created but no disc implanted. Horses were 
confined to a stall for 1 month post-operatively, 
then walked 10 min twice daily and their exercise 
increased by 5 min weekly for a period of 4 weeks. 
The horses were then turned out on half an acre 
pasture until euthanasia t 120 days (six horses) or 
240 days (six horses). The horses were euthanized 
and the stifle joints removed without opening the 
joint capsule. A sterile scalpel blade was used to 
harvest he repair tissue from the axial one-third of 
the defect. The repair tissue up to but not including 
the subchondral bone was harvested. Separate car- 
tilage samples were harvested 8-10 mm remote to 
the defect and from the medial trochlea within 
each joint. The excised tissue was dipped in chilled 
protease inhibitor (1.01% disodium EDTA, 1.21~/o 
Tris base, 0.125% N-ethylmaleimide, 0.0156% ben- 
zamidine HC1, 0.0174~/o phenylmethyl-sulfonylfluo- 
ride, 2.2~/o N-propanol; adjusted to a pH of 7.4) and 
placed in a vial and frozen at -80°C. 
COLLAGEN ANALYSIS 
Cyanogen bromide (CB) peptides of type I 
and type I I  collagen 
Cartilage from the lateral trochlea of the stifle, 
and tendon from the mid-metacarpal region of the 
superficial digital flexor tendon, were harvested 
from a 2-year-01d normal horse. The samples 
were rinsed in protease inhibitor, wrapped in 
Gey's balanced salt solution (GBSS; GIBCO-Life 
Technologies Inc., Grand Island, NY)-soaked paper 
towels, and placed in sealed plastic centrifuge 
tubes. The samples were then immediately frozen 
at -70°C. The samples were pulverized in liquid 
nitrogen (Spexmill), weighed, lyophilized, and 
reweighed to determine water content. The tissue 
was transferred to conical glass tubes containing 
70% deaerated formic acid. A volume of solid 
cyanogen bromide (CB) at least twice that of the 
tissue sample to be cleaved was added to each 
conical tube. The contents were incubated, with 
gentle agitation, for 5 h in a 30°C water bath. The 
cleavage was halted by adding five volumes of 
purified filtered H20. 
Amino acid analysis 
Amino acid content in CB-cleaved samples was 
analyzed utilizing reverse phase high pressure 
liquid chromatography (Waters Division, Milli- 
pore Corp., Milford, MA). The tissue was wet 
hydrolyzed in 6N HC1 at 110°C for 22h in a 
Pico-Tag work station. The hydrolysates were 
dried, derivatized with phenylisothiocyanate and 
analyzed using the Pico-Tag TM amino acid analysis 
system. The percentage collagen and the hydroxy- 
lysine to hydroxyproline ratio were estimated from 
the amino acid analysis [31, 32]. Results were 
reported as the approximate percentage collagen 
on a dry weight basis and collagen as a percentage 
of the total protein present. 
Gel electrophoresis 
To analyze CB peptides, lyophilized samples of 
CB digested and non-CB digested equine tendon, 
equine cartilage, rat tail collagen and collagen 
scaffold were solubilized in sample buffer (Tris, 
sodium dodecyl sulfate, glycerol and bromophenol 
blue) to form a 2/~g collagen/#l solution, and 12/~g 
of each placed in lanes of a 12% SDS polyacryl- 
amide gel [8, 33, 34]. The collagens from tendon and 
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cartilage were used as standards for type I and type 
II collagen, respectively [2-4, 35]. Samples contain- 
ing varying proportions of CB peptides from type 
I and type II collagen, starting with 100~/o type 1 
(tendon) collagen, and ending with 100% type II 
collagen, were made in a sample buffer base at 
2/~g//~l. Three duplicate standard gels containing 
the 11 samples were formed (Fig. 1). The gels were 
fixed, stained with coomassie blue, destained, and 
equilibrated in 50~/o glycerol. Wet gels were densit- 
ometrically scanned (Ultrascan XL TM soft laser 
densitometer, Pharmacia LKB Biotechnology, 
Sweden), and CB peptide bands computer-inte- 
grated. The area under the peaks al(II)CB 10 and 
a2(I)CB 3,5+, representing type I and type II 
collagen, were used to form a ratio. Crosslinked 
fragments and attached telopeptides have been 
identified in a2(I)CB3,5, [35, 36]; we have labeled it 
a2(I)CB3,5 +. Ratio values from 20~/o to 80% type II 
collagen from the three standards were averaged to 
plot the slope of the line. 
The repair tissue was CB-digested and separated 
by SDS PAGE, in an identical protocol to the 
standards. The ratio of areas of the computer- 
integrated CB peptide peaks were compared to 
known ratios on the standards, and the percentage 
of type II collagen in the repair tissue samples 
determined. 
To determine the CS and KS content, aliquots of 
0.1ml papain-digested tissue were incubated at 
37°C for l h with either 10ttl of a 0.05U/ml 
chondroitinase ABC (Seikagaku Kogyo, Tokyo, 
Japan) solution or a 0.1 U/ml keratanase solution 
(Seikagaku) and the resultant digests were then 
assayed using the DMMB method to determine the 
levels KS and CS, respectively [30]. Duplicate 
samples were run for all specimens; the results 
were averaged and reported as #g/mg of tissue dry 
weight. 
STAT IST ICAL  ANALYSIS 
Comparison of the collagen and GAG data from 
chondrocyte-transplanted an control stifles at 
each time period was done using the Student's 
paired t-test, since each animal served as its own 
control. Comparison of the changes in data from 
treated and control groups over the sampling time 
periods was then performed by repeated measures 
analysis of variance. Significant interactions of 
treatment (graft or control) or time were assessed. 
The level of significance was P ~< 0.05. Statistical 
analyses were performed using SAS statistical soft- 
ware (SAS Users Guide, Statistics, 1990, Cary, NC). 
Collagen content and typing of the collagen scaffold 
A sample of the collagen scaffold was weighed, 
CB-digested, and analyzed with SDS PAGE and 
amino acid analysis. 
"GAG ANALYSIS 
Repair tissue from the defects, cartilage from an 
area 8-10 mm away from the edge of the defect, and 
cartilage from the central aspect of the medial 
trochlea of each joint were harvested. Cartilage 
from the lateral central one-third of the lateral 
trochlea of six normal horses, aged 2-8 years, was 
also harvested. All samples were blotted dry, 
weighed, lyophilized, and reweighed to determine 
dry weight. 
Glycosaminoglycan (GAG) assays were per- 
formed using the dimethylmethylene blue (DMMB) 
spectrophotometric method. Samples were digested 
in 0.5 mg/ml papain at 65°C for 4 h. A 50-#1 aliquot 
of the digest was then assayed for total GAG by 
addition of 2.5ml DMMB solution (in formate 
buffer) and the absorbance immediately read at 
525 nm in a spectrophotometer. Thestandard curve 
:~was constructed using mixed isomers of CS. 
Resu l ts  
COLLAGEN ANALYSIS 
Total collagen, proportion of type II collagen, 
hydroxylysine (Hyl) to hydroxyproline (Hyp) 
ratios, and water content of normal cartilage and 
tendon, repair tissues, and unladen collagen 
scaffold are presented in Table I. The water con- 
tent of normal cartilage and tendon was 68.9~/o and 
49.5~/o, respectively. These values are consistent 
with published normal values in other species 
[1, 37-39]. The water contents of the control and  
experimental repair tissues were not significantly 
different o normal cartilage (Table I). There was 
no significant difference in total collagen content 
(as a. percentage of protein) of the repair tissue 
between the grafted and nongrafted sites at either 
4 or 8 months. Similarly, there was no difference in 
collagen content between the 4 and 8 month 
groups. The Hyl:Hyp ratios derived from amino 
acid analysis of normal cartilage and tendon were 
0.141 and 0.128, respectively. The collagen scaffold 
had a Hyl:Hyp ratio of 0.202. There was a signifi- 
cant difference in the Hyl:Hyp ratio of grafted 
compared to control defects at 8 months, due to a 
decline in the ratio determined for control tissues 
(0.101). 
64 Sams et al.: Local and remote  matr ix  responses to implants  
Table I 
Total collagen, proportion of type H collagen, Hyl : Hyp ratio and water content values of the grafted and ungrafted 
repair tissues at 4 and 8 months, and of normal cartilage and tendon, and dry collagen scaffold prior to 
chondrocyte loading 
Collagen 
Survival time content Type II collagen Water content 
(months) Tissue source Hyl:Hyp ratio (% -~ S.E.M.) (% ~__ S.E.M.) (% -}- S.E.M.) 
4 (N = 6) 
4 (N = 6) 
8 (N = 6) 
8 (N = 6) 
Normal cartilage 0.141 a 91.70 __ 9.24 100 68.96°/0 
Normal tendon 0.128 b 100 ± 9.24 0 49.53~/o 
Collagen scaffold 0.202 c 100 _+ 6.53 0 0 
Experimental 0.113 d 98.00 _+ 0.82 a 28.45 _+2.76 a 74.82 + 1.28 a 
Control 0.111 d 91.25 _+ 4.10 a 28.17 + 2.76 a 72.18 _+ 2.18 a 
Experimental 0.112 d 92.16 _+ 1.50 a 31.57 + 2.76 ~ 75.25 + 2.24 a 
Control 0.101 e 85.80 _+ 3.22 a 26.88 + 2.76 a 69.61 + 5.62 a 
Values with different superscript letters are significantly different (P < 0.05). 
The SDS PAGE of non pepsin-digested CB- 
cleaved products from equine tendon and equine 
cart i lage demonstrated CB peptide bands charac- 
teristic of pepsin-digested CB-cleaved type I and 
type II collagen, a l though somewhat wider (Fig. 1) 
[35]. Normal cart i lage produced discrete CB pep- 
tides al( I I )CB10 and ~I ( I I )CBl l  which could be 
isolated for accurate integrat ion on the densit- 
ometer scan (Fig. 2). Tendon produced a wide 
~2(I)CB3,5 referred to as ~2(I)CB3,5+ (Fig. 3). 
Peptide bands ~I(I)CB7,6, a2(I)CB4, a I(I)CB8 and 
~I(I)CB3 were similar to those identified pre- 
viously [35]. The col lagen scaffold produced a 
single poorly migrat ing band that  did not interfere 
with the CB peptides of the cart i lage and tendon 
(Fig. 4). The SDS PAGE of the repair tissues from 
some horses had denser ~l(II) CB 10 bands in the 
grafted compared to control  samples (Fig. 4). Inte- 
grat ion profiles showed a mixture of type I and type 
II col lagen (Fig. 5). The proport ion of type I I  
col lagen in the chondrocyte grafted repair  tissue 
varied from 24.9-37.8% and was not signif icantly 
different o control  repair tissue at 4 and 8 months. 
Addit ional ly,  there was no signif icant difference in 
type II col lagen content  between the 4 and 8 month 
groups. 
GAG ANALYSIS 
The total  GAG, CS and KS values for  repair 
tissue in the defects, cart i lage surrounding the 
defects, the medial t rochlea from the operated 
joints, and cart i lage from the lateral t rochlea in 
normal  joints are reported in Table II. At 4 months 
there was a greater percentage of total  GAG, CS 
and KS in the experimental  compared to control  
a2(I)CB3~5+- 
al(I)CB7,6 - 
~ chains 
~" a chains 
.* (~2(II)CB10 
a2(I)CB4- . al(II)CBll 
al(I)CB8 - 
al(I)CB3 - 
- a I ( I I )CB12 
- a I ( I I )CB9,7 
- al ( I I )CB6 
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FIG. 1. Photograph of a 12% polyacrylamide gel of varying concentrations of CB digested equine type I (tendon) 
collagen and CB digested equine type II (cartilage) collagen used as a standard for determination of the percentage 
type II collagen in the repair tissue. First and last lane contain undigested rat tail collagen. 
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FIG. 2. Computer integration profile of a laser densit- 
ometer scan of type H (cartilage) collagen CB peptides 
used for development of the standard. 1 = a l(II)CB10; 
2 = ~I(II)CBll. 
FIG. 3. Computer integration profile of a laser densit- 
ometer scan of type I (tendon) collagen CB peptides 
used for development of the standard. 1 = ~ 2(I)CB3,5 + ; 
2 = ~I(I)CB7,6; 3 = a2(I)CB4; 4 = al(I)CBS; 5 = al(I)CB3. 
repa i r  t issue. However,  the dif ference was not 
stat is t ica l ly  signif icant. At  8 months,  tota l  GAG 
was s ignif icant ly increased in the grafted defects. 
The CS and KS values exhibi ted s imi lar  trends. 
The proport ions  of KS as a percentage of tota l  
GAG in repa i r  t issues and in cart i lage from normal  
latera l  t roch lea  are reported in Table  III. 
Immediate ly  ad jacent  to the defects, there was 
no s ignif icant dif ference in the concentrat ions  of 
tota l  GAG, CS and KS at 4 months.  However,  at 8 
months  the tota l  GAG content  of cart i lage sur- 
rounding grafted defects was s ignif icant ly greater  
than  cart i lage around contro l  defects. The tota l  
GAG content  in lateral  t roch lea  cart i lage from 
normal  jo ints  was approx imate ly  three t imes that  
of the GAG in repai r  t issues and approx imate ly  1.7 
greater  than  the GAG content  in the car t i lage 
sur round ing  the defects. 
Discuss ion  
Chondrocyte-co l lagen composites improved 
some of the b iochemica l  character is t ics  of  repa i r  
t issue and sur round ing  cart i lage 8 months  after  
implantat ion.  There  was a s ignif icant ly greater  
tota l  GAG content  in exper imenta l  repa i r  t issues 
compared to ungraf ted controls.  Addit ional ly,  the 
GAG values of the cart i lage sur rounding the defect 
in the 8 month  grafted group were better  main- 
ta ined than  those in the cart i lage sur round ing  the 
defect in nongraf ted joints,  suggest ing that  the 
deleter ious effects of a full th ickness ar t i cu la r  
T R 1 1 2 2 3 3 4 4 R Ca D 
a2(I)CB3,5+ - -  
al(I)CB7,6 
a2(I)CB4 
al(I)CB8 
al(I)CB3 -.... 
aI(II)CB10 
al(II)CBll 
E C E C E C E C 
FIG. 4. Photograph of a representative 12~/o polyacrylamide gel showing CB peptides of horses 1 to 4. E = experimental, 
C = control, D = CB collagen scaffold disk peptides, T = type 1 (tendon) peptides, Ca = type II (cartilage) peptides, 
R = undigested rat tail collagen. 
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Table II I  
Repair tissue and normal cartilage keratan sulfate as a 
proportion of total GAG 
KS/total  KS/tota l  
GAG GAG 
(Pg//~g) (%) 
Exper imental  120 days 
Control 120 days 
Exper imental  240 days 
Control 240 days 
Normal lateral  t rochlea 
5.68/62.05 9.1 
5.04/53.71 9.0 
7.35/83.61 8.8 
7.24/84.91 9.7 
50.6/214.00 23 
Fro. 5. An example of a computer integrat ion profile 
from a laser densitometer scan from grafted repair  
tissue. 1 = ~2(I)CB3,5+; 2 = ~I(II)CB10; 3 = ~2(I)CB4; 
4 = ct I(I)CB3. 
defect  were  d imin ished  by the  chondrocyte  graf ts .  
However ,  there  was  no s ign i f i cant  d i f fe rence  in  the  
percentage  of  type  I I  co l lagen  in gra f ted  and  con- 
t ro l  repa i r  t i ssues.  
Tota l  GAG content  in exper imenta l  repa i r  t i ssue  
at  8 months  was  s ign i f i cant ly  h igher  than  cont ro l s ,  
demonst ra t ing  surv iva l  of  g ra f t  cel ls  and  synthet ic  
ac t iv i ty .  Never the less ,  the  s low accumulat ion  of  
GAG suggests  an  inadequate  number  of  ce l ls  were  
in i t ia l l y  g ra f ted  or  a smal l  number  of cel ls  surv ived  
and  8 months  was  requ i red  to accumulate  suf f ic ient  
GAG to show a s ign i f i cant  d i f ference.  P rev ious  
s tud ies  w i th  chondrocytes  in f ibr in  [26, 40], and  
chondrocytes  in co l lagen  scaf fo lds  [28, 30], suggest  
the  number  of  ce l ls  g ra f ted  was  adequate ,  but  
fu r ther  s tud ies  a re  necessary  to determine  the  
idea l  number .  In vitro s tud ies  suggest  that  a 
greater  ce l l  dens i ty  is benef i c ia l  for  GAG pro-  
duct ion  [40]. 
The  content  of  CS and  KS  in exper imenta l  and  
cont ro l  de fects  at  8 months  was  not  s ign i f i cant ly  
d i f ferent ,  desp i te  the  appearance  of  a t rend.  The  
var iance  of  another  d igest ,  the  smal le r  abso lu te  
va lues  o f  th is  GAG subset ,  and  the  smal l  d i f fe rence  
in to ta l  GAG in i t ia l l y ,  p robab ly  account  for 
the  lack  of  s ign i f i cant  d i f fe rences  in GAG types  
between exper imenta l  and  cont ro l  jo in ts .  The  
va lues  of  KS  as a percentage  of  to ta l  GAG 
in  the  4 and  8 month  repa i r  t i ssue  were  a lso  low. 
Table II 
Total GAG, chondroitin sulfate and keratan sulfate content for cartilage repair tissue, cartilage adjacent 
to grafted and ungrafted efects, cartilage from the medial trochlea, and for cartilage from lateral 
trochlea of normal femoropatellar joints 
GAG pg/mg CS #g/mg KS ttg/mg 
(Mean ,+ S.E.M.) (Mean ± S.E.M.) (Mean ,+ S.E.M.) N 
Repair tissue 
Exp. 120 days 62.05 _+ 7.51 a 41.02 + 2.42 a 5.68 + 0.65 a 12 
Cont. 120 days 53.71 ,+ 5.87 a 37.49 ± 1.90 a 5.04 _+ 0.60 a 12 
Exp. 240 days 85.61 ___ 6.51 a'f'g 46.36 ,+ 1.13 a 7.35 ,+ 1.14" 12 
Cont. 240 days 74.91 ,+ 10.31 ~s 41.19 ,+ 3.69" 7.14 _+ 2.28 ~ 12 
Surrounding cart i lage 
Exp 120 days 127.07 ,+ 1.92 b,c 51.32 ,+ 0.32 a 30.82 + 1.84 b 6 
Cont. 120 days 123.37 ,+ 1.60 b,c 49.80 ,+ 0.56 a 28.73 ,+ 0.82 ~ 6 
Exp. 240 days 137.56 ,+ 14.74 b 58.46 ,+ 8.32" 31.76 ,+ 1.81 b 6 
Cont. 240 days 116.32 _+ 6.72 b,e,f 47.41 ,+ 2.34" 25.54 + 3.47 b 6 
Medial  trochlea cart i lage 
Exp. 120 days 264.80 ,+ 29.72 c 188.39 ,+ 21.45 c 52.17 ± 10.12 ~ 6 
Cont. 120 days 248.61 ,+ 31.07 c,g 182.58 ± 24.11 ~ 51.20 ,+ 12.02 ~ 6 
Exp. 240 days 186.26 ,+ 28.87 d 132.75 _+ 19.51 b 35.27 ,+ 8.5 b 6 
Cont. 240 days 181.25 ± 25.46 d 129.93 ,+ 17.56 b 36.34 +_ 7.14 b 6 
Normal lateral  t rochlea cart i lage 214.00 ± 13.90 d,g 171.54 + 12.75 c 50.56 _+ 9.82 ° 5 
Exp. = experimental; Cont. = control. 
Within each column, values with different superscript letters are significantly 
All values are on a dry weight basis. 
different (P < 0.05). 
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Macromolecular biochemical markers of dediffer- 
entiation include decreased KS synthesis, mainten- 
ance of CS and otl~er GAG moieties and less type 
II collagen production [41, 42]. Adult cartilage is 
rich in chondroitin-6-sulfate and keratan sulfate 
compared to immature cartilage, which contains 
predominantly chondroitin-4-sulfate [43-48]. 
Therefore, low KS and type II collagen content 
could indicate that grafted cells reverted to a more 
primitive chondrocytic ell or were replaced by 
fibroblasts. Without cell markers, the origin of 
the cells in the experimental defect could not be 
determined. 
There were no significant differences in the 
GAG, CS and KS values of surrounding cartilage 
at 4 months. These findings suggest hat the insult 
to the remaining articular cartilage in close prox- 
imity to the defect was similar in grafted and 
control joints. This is supported by the results of 
synovial fluid analysis, synovial membrane hist- 
ology, and the histochemical evaluation of this 
cartilage, described previously [24]. However, 
cartilage GAG content adjacent to the defects 
was reduced by approximately 42~/o compared to 
normal lateral trochlear cartilage (Table II), 
suggesting that the cartilage defect had a deleteri- 
ous effect on surrounding cartilage. This effect 
may have extended to the medial trochlear carti- 
lage by 8 months. Over longer time periods (8 
months), total GAG in the surrounding cartilage 
was higher in the grafted joints, suggesting in- 
creased matrix GAG depletion from the surround- 
ing cartilage of the control defects due to the 
delayed healing. Despite these positive aspects, 
repair tissue and cartilage 5-10 mm adjacent o the 
defects contained GAG levels significantly lower 
than cartilage from normal lateral trochlear 
ridges. Longer maturation of the repair tissue may 
be required to allow the surrounding cartilage to 
approach normal GAG values. The poor total GAG 
content of repaired defects at 8 months suggests 
that cartilage lesions implanted with chondrocyte- 
laden collagen scaffolds may never reach normal 
values, although the chondrocyte graft appeared to 
result in improved GAG levels compared to those 
in the ungrafted control defects. This finding 
supports the histochemical results previously 
reported, where increased pericellular safranin 
staining was evident in grafted defects [24]. The 
lower GAG, CS and KS values in defect repair 
tissues, compared to the surrounding tissue and to 
normal cartilage, reflect the primarily fibroblast- 
laden surface and middle zones of the defect. Fur- 
thermore, the loss of tissue in the defect is known 
to increase the mechanical load on the surround- 
ing tissue [49], and combined with the exposure of 
the full thickness of carti lage through the walls of 
the defect, resulted in loss of GAG in the surround- 
ing cartilage. Local chondrocyte death from the 
drilling procedure may also have played a role. 
Remote cartilage on the medial trochlea was not 
subjected to altered biomechanical forces, and thus 
alterations in GAG values could only be attribut- 
able to biochemical changes within the joint. The 
8 month medial trochlea GAG values were signifi- 
cantly lower than the 4 month values. This may 
have been due to a low level synovitis at 8 months, 
with eytokine-suppressed total GAG production, or 
an increased loss of GAG into the joint. Since 
normal medial trochlea GAG values are unknown, 
the chondrocytes at 4 months may have been 
responding to low grade inflammation throughout 
the joint by increased synthesis and at 8 months 
this had declined and GAG production was again 
normal. 
The percentage collagen in the repair tissues as 
a percentage of total protein was similar in grafted 
and control tissue and was high, suggesting that 
both tissues contained collagen as the primary 
product of protein synthesis. There were no signifi- 
cant differences in the percentage of type II colla- 
gen in grafted or ungrafted efects at 4 or 8 months 
and the proportion of type II collagen did not 
significantly increase between 4 and 8 months. 
Previous studies, using equine chondrocytes im- 
planted in fibrin, resulted in 62% type II collagen 
at 8 months [26] and would appear superior to the 
collagen scaffold used here. However, neither im- 
plant resulted in the type II collagen levels present 
in normal cartilage. 
Studies on the collagens in normal equine carti- 
lage have been reported [34, 35, 50]. Vachon et al. 
[51] determined the percentage of type II collagen 
in cyanogen bromide cleaved repair tissue of 
equine radial carpal bones following autogenous 
periosteal grafts. Cyanogen bromide cleaves colla- 
gen at methionine bonds and produces character- 
istic peptides of different size and charge from type 
I and type II collagen. The ~ I(II)CB10 and ~ I(I)CB7 
bands using SDS PAGE were used as relative 
markers of type H and type I collagen, respectively 
[51]. However, recent studies showed that there is 
no ~I(I)CB7 in the horse [35]. These investigators 
used the average of ~l(I) CB 7,6 and ~2(I) CB 4 as 
a more consistent marker of type I collagen in 
equine cartilage repair tissues [26]. The CB-di- 
gested cartilage from experimental and normal 
joints produced CB peptide bands that generally 
separated clearly from the other bands with PAGE. 
The occasional oss of clear distinction between 
bands or increased width of bands in this study 
resulted from omitting the pepsin digestion. Pepsin 
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cleaves the amino and carboxyl telopeptides [52], 
and has been a routine step in previous studies 
[34, 35, 50, 51, 53]. It was eliminated from the cur- 
rent protocol because of small sample size. The 
variable cross-links and telopeptides remaining on 
the amino and carboxyl ends of the ~ chains give 
greater variability in size and charge of the CB 
peptide bands, leading to wider, less distinct, bands 
on the SDS PAGE of repair tissue. The lysyl- 
derived cross-links of both type I and type H 
collagen are located between the telopeptide and 
AA930 and 87 in the triple helix. However, even 
without pepsin digestion, discrete ~ I(II)CB10 and 
~I(II)CBll bands were clearly evident on the gel. 
Type I collagen peptide bands ~2(I)CB3,5+, 
I(I)CB7,6, ~2(I)CB4, ~ I(I)CB8 and ~ I(I)CB3 were 
also present and easily discernable. The ~ 2(I)CB3,5 
was not pure because of the telopeptides and cross- 
linked material. Therefore we describe it as 
~2(I)CB3,5+. Different ratios were evaluated to 
find those that most accurately predicted the 
known amounts of type II collagen. The 
~I(II)CB10/~2(I)CB3,5+ ratio had the least over- 
lapped laser densitometer peaks, allowing the most 
accurate calculation of the area under the peaks 
on integration. This resulted in the ratio that best 
determined the amounts of collagen in the stan- 
dard. In establishing the standard using stepwise 
inversely varying concentrations of type I and type 
II collagen, the values from 20-80% type II were 
used because at 0% type I or type II, and at 100~/o 
type I or II, either the numerator or the denomi- 
nator in the peptide ratio tended toward zero or 
infinity. The standard was linear within the 
20-80°//0 concentrations, and the type II collagen 
proportion was determined from those values. All 
of the repair tissue results fell within the 20-80% 
range, eliminating possible inaccuracies associ- 
ated with the ends of the standard curve. 
The Hyl:Hyp ratios for normal tendon (0.128) 
and cartilage (0.141) are consistent with their 
structure; previous studies show increased 
hydroxylysine in type II collagen compared to type 
I [35]. As such, the Hyl: Hyp ratio has been used in 
the past as an indicator of the percentage of type 
II collagen [31, 32]. However, in this study the 
Hyl:Hyp ratio in repair tissue was lower than that 
of either tendon or cartilage collagen at all time 
points, and considerably lower than the ratio for 
the implanted collagen scaffold (0.20). Compared to 
semiquantitative analysis by CB peptide ratios on 
SDS PAGE, the Hyl:Hyp ratio can be derived 
simply using HPLC. The significantly increased 
Hyl:Hyp ratio from grafted tissues, compared to 
controls, suggests the presence of more active 
chondrocytic cells in the experimental defects [31]. 
Nevertheless, repair tissue ratio values were lower 
than tendon type I collagen ratios, and consider- 
ably lower than type II ratios, and although com- 
parison of grafted and ungrafted tissue was 
possible, the validity of these ratios as an estimate 
of proportions of type I and II collagen is clearly 
questionable. 
The percentage water in the experimental de- 
fects was similar to that of normal cartilage. How- 
ever, immature or less cellular fibrous repair tissue 
would have a similar water content, being con- 
siderably less dense than tendon. The percentage 
water reveals little about the type of tissue in the 
defect. Furthermore, there was no difference be- 
tween experimental nd control tissue. 
In conclusion, biochemical evidence was sugges- 
tive of a more cartilage-like repair tissue in the 
chondrocyte-grafted defects. However, the differ- 
ences were not marked, and by the end of the 
8-month study, neither grafted nor control repair 
tissue contained biochemical marker values con- 
sistent with normal cartilage. 
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